Keywords: novartis, buys, majority, stake, idenix, europe, third-largest
Novartis buys majority stake in Idenix
Article | 31 March 2003
Europe's third-largest drugmaker, Novartis, is set to acquire acontrolling stake in, and certain product rights from, privately-held, USA-based biotechnology concern ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
